Sign up for Table of Contents Alerts.
Email this page
Print this page
Review
Oncogenic Transformation by the Signaling Adaptor Proteins Insulin Receptor Substrate (IRS)-1 and IRS-2
Robert K. Dearth, Xiaojiang Cui, Hyun-Jung Kim, Darryl L. Hadsell and Adrian V. Lee
volume 6 | issue 6
15 March 2007Pages: 705 - 713
This is an open-access article
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Insulin receptor substrates (IRSs) are adaptor proteins that link signaling from upstream activators to multiple downstream effectors to modulate normal growth, metabolism, survival, and differentiation. Recent cell culture studies have shown that IRSs can interact with, and are functionally required for, the transforming ability of many oncogenes. Consistent with this, IRSs are elevated and hyperactive in many human tumors. IRSs respond to many extracellular signals that are critical for mammary gland development, and we have shown that IRSs disrupt normal mammary acini formation in vitro, and cause mammary tumorigenesis and metastasis in vivo. In this review we will discuss the role of IRSs in both transformation and cancer progression.
Authors
Robert K. Dearth
Baylor College of Medicine, Houston, TX
Xiaojiang Cui
Baylor College of Medicine, Houston, TX
Hyun-Jung Kim
Baylor College of Medicine, Houston, TX
Darryl L. Hadsell
Baylor College of Medicine, Houston, TX
Adrian V. Lee
avlee@breastcenter.tmc.edu
This is an open-access article
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.




